Home › Funds › Murchinson Ltd. › MRNA

Murchinson Ltd. position in MRNA

MODERNA INC · Health Care

Murchinson Ltd. reported holding 30,000 shares of MRNA (MODERNA INC) in its Q3 2026 13F filing — a position valued at US$5.8M, representing 1.10% of its reported portfolio and ranking #24 among its reported holdings. Murchinson Ltd. has disclosed MRNA holdings in 2 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)30.00K sh
Reported value held$5.78M
Portfolio Weight1.10%
First reportedQ4 2025
Last changeNew
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Murchinson Ltd.'s MRNA position evolved

Murchinson Ltd. first disclosed a stake in MRNA in Q4 2025 at 200,000 shares (US$5.9M). Across 2 filings, Murchinson Ltd. held the position steady without any share-count change. The most recent filing (Q3 2026) shows 30,000 shares valued at US$5.8M.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 200.00K $5.90M New
Q3 2026 30.00K $5.78M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MRNA and 13F data

MRNA (MODERNA INC) is a Health Care company. 42 other funds we track also report a position in MRNA — the largest reported positions include Fidelity Management & Research (FMR) (US$11.35B), Capital World Investors (US$4.36B), Baillie Gifford & Co (US$2.20B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRNA

All MRNA fund holders →

FAQ

How long has Murchinson Ltd. held MRNA?

Murchinson Ltd. has disclosed MRNA holdings in 2 of the last 4 reported quarters, going back to Q4 2025.

What is Murchinson Ltd.'s current position in MRNA?

As of Q3 2026, Murchinson Ltd. holds 30.00K shares of MRNA (MODERNA INC), valued at $5.78M, representing 1.10% of its reported portfolio and ranking #24.

Has Murchinson Ltd. been buying or selling MRNA?

In the latest 13F filing (Q3 2026), Murchinson Ltd. newly opened its position in MRNA.

Which other funds hold MRNA?

Other major institutional holders of MRNA include Fidelity Management & Research (FMR), Capital World Investors, Baillie Gifford & Co, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.